Chia Tai Enterprises International Limited
Chia Tai Enterprises International Limited
Your view on CAIHF
Overview
What the company does, where it operates, and who runs it.
About Chia Tai Enterprises International Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Thirayut Phityaisarakul
- Headquarters
- Far East Finance Centre, Central, HK
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Thirayut Phityaisarakul
- Headquarters
- Far East Finance Centre, Central, HK
Chia Tai Enterprises International Limited engages in the manufacture and sale of chlortetracycline (CTC) and other related products in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial.
The Biochemical segment manufactures and sells CTC premix and CTC hydrochloride products, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brands.
The Industrial segment engages in the sale, leasing, and servicing of caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as spare parts; and manufacture and sale of carburetors and automotive parts for automobile and motorcycle manufacturers.
The company was incorporated in 1987 and is based in Central, Hong Kong. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Chia Tai Enterprises International Limited, and the rating behind it. CAIHF last traded at $0.28, 11.2× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Chia Tai Enterprises International Limited. Starting points for Chia Tai Enterprises International Limited: P/E 11.2, EPS $0.10, beta 3.18 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Chia Tai Enterprises International Limited. Chia Tai Enterprises International Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Chia Tai Enterprises International Limited. Trailing twelve-month EPS for Chia Tai Enterprises International Limited stands at $0.10. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Chia Tai Enterprises International Limited. Chia Tai Enterprises International Limited has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Chia Tai Enterprises International Limited valued side by side against its closest peers. Chia Tai Enterprises International Limited is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Chia Tai Enterprises International Limited, and how their positions are changing. At a $217.4M market value, institutional positions materially move Chia Tai Enterprises International Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Chia Tai Enterprises International Limited executives and directors. Shares of Chia Tai Enterprises International Limited have traded between $0.0015 and $0.28 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Chia Tai Enterprises International Limited. Chia Tai Enterprises International Limited is a $217.4M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Chia Tai Enterprises International Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Chia Tai Enterprises International Limited. Coverage tracks Chia Tai Enterprises International Limited within Biotechnology (Healthcare). Press releases and market coverage, newest first.